Back to Search
SULOCHANA BHANDARKAR, MD
MD
Dermatology Physician
NPI: 1215114368IndividualAccepts Medicare
Education
OTHER
Class of 1998
Research & Publications (20)
Efficacy of topical application of eosin for ulcerated hemangiomas.
PMID 19150285·J Am Acad Dermatol·2009
8-other
Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.
PMID 19620773·J Clin Invest·2009
7-preclinical
Virtual multi-fracture craniofacial reconstruction using computer vision and graph matching.
PMID 19345066·Comput Med Imaging Graph·2009
8-other
Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo.
PMID 17914455·J Invest Dermatol·2008
7-preclinical
Targeted therapy of oral hairy leukoplakia with gentian violet.
PMID 18342722·J Am Acad Dermatol·2008
5-case
Likelihood of a particular order of genetic markers and the construction of genetic maps.
PMID 18324750·J Bioinform Comput Biol·2008
8-other
Photopic pupillometry-guided laser in situ keratomileusis for hyperopic presbyopia.
PMID 18242441·J Cataract Refract Surg·2008
8-other
The antidepressant sertraline downregulates Akt and has activity against melanoma cells.
PMID 18710373·Pigment Cell Melanoma Res·2008
7-preclinical
Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo.
PMID 18794083·Clin Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 425 UNIVERSITY BLVD
ROUND ROCK, TX 78665 - Phone
- (512) 509-0200
Quick Facts
- NPI
- 1215114368
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile